Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells-Reference-Cited by-同舟云学术

Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells

Published:2014-07-22 Issue:13 Volume:74 Page:1347-1358
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Arndt Claudia¹,Feldmann Anja¹²,Töpfer Katrin³,Koristka Stefanie¹,Cartellieri Marc¹²,Temme Achim³,Ehninger Armin¹⁴,Ehninger Gerhard⁴,Bachmann Michael¹²⁵

Affiliation:

1. Medical Faculty ‘Carl Gustav Carus’ TU Dresden; Institute of Immunology; Dresden Germany

2. Department of Radioimmunology; Helmholtz-Zentrum Dresden-Rossendorf; Institute of Radiopharmaceutical Cancer Research; Dresden Germany

3. Department of Neurosurgery; Section Experimental Neurosurgery/Tumor Immunology; University Hospital ‘Carl Gustav Carus’ TU Dresden; Dresden Germany

4. Medical Clinic and Polyclinic I; University Hospital ‘Carl Gustav Carus’; TU Dresden; Dresden Germany

5. Center for Regenerative Therapies Dresden; ‘Carl Gustav Carus’; TU Dresden; Dresden Germany

Funder

MeDDrive

Robert Pfleger Stiftung

CRTD

SFB 655

José Carreras Stiftung

Publisher

Wiley

Subject

Urology,Oncology